Literature DB >> 28174214

Excitotoxicity-induced prostaglandin D2 production induces sustained microglial activation and delayed neuronal death.

Kensuke Iwasa1, Shinji Yamamoto1, Sosuke Yagishita1, Kei Maruyama1, Keisuke Yoshikawa2.   

Abstract

Excitotoxicity is the pivotal mechanism of neuronal death. Prostaglandins (PGs) produced during excitotoxicity play important roles in neurodegenerative conditions. Previously, we demonstrated that initial burst productions of PGD2, PGE2, and PGF2α are produced by cyclooxygenase-2 (COX-2) in the hippocampus following a single systemic kainic acid (KA) administration. In addition, we showed that blocking of all PG productions ameliorated hippocampal delayed neuronal death at 30 days after KA administration. To investigate the role of individual PGs in the delayed neuronal death, we performed intracerebroventricular injection of PGD2, PGE2, or PGF2α in rats whose hippocampal PG productions were entirely blocked by pretreatment of NS398, a COX-2 selective inhibitor. Administration of PGD2 and PGF2α had a latent contribution to the delayed neuronal death, sustained over 30 days after a single KA treatment. Furthermore, PGD2 enhanced microglial activation, which may be involved in the delayed neuronal death in the hippocampus. These findings suggest that excitotoxic delayed neuronal death is mediated through microglia activated by PGD2.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  kainic acid; microglia; neurons

Mesh:

Substances:

Year:  2017        PMID: 28174214      PMCID: PMC5392741          DOI: 10.1194/jlr.M070532

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  36 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells.

Authors:  Clive Bate; Sarah Kempster; Alun Williams
Journal:  Neuropharmacology       Date:  2005-11-11       Impact factor: 5.250

3.  Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury.

Authors:  Muzamil Ahmad; Abdullah Shafique Ahmad; Hean Zhuang; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2007-02-02       Impact factor: 3.478

4.  Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.

Authors:  J Y Crider; B W Griffin; N A Sharif
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 5.  Glutamate in neurologic diseases.

Authors:  P Bittigau; C Ikonomidou
Journal:  J Child Neurol       Date:  1997-11       Impact factor: 1.987

Review 6.  Neuroprotection by tetracyclines.

Authors:  María Domercq; Carlos Matute
Journal:  Trends Pharmacol Sci       Date:  2004-12       Impact factor: 14.819

Review 7.  Prostaglandin E receptors.

Authors:  Yukihiko Sugimoto; Shuh Narumiya
Journal:  J Biol Chem       Date:  2007-02-28       Impact factor: 5.157

Review 8.  Prostanoids and inflammation: a new concept arising from receptor knockout mice.

Authors:  Shuh Narumiya
Journal:  J Mol Med (Berl)       Date:  2009-07-17       Impact factor: 4.599

9.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

Review 10.  Physiology and pathophysiology of prostanoid receptors.

Authors:  Shuh Narumiya
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2007-12       Impact factor: 3.493

View more
  7 in total

Review 1.  Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury.

Authors:  Heena Khan; Kunal Sharma; Amit Kumar; Amarjot Kaur; Thakur Gurjeet Singh
Journal:  Inflamm Res       Date:  2022-02-17       Impact factor: 4.575

Review 2.  Sleep Disturbance and Alzheimer's Disease: The Glial Connection.

Authors:  Aditya Sunkaria; Supriya Bhardwaj
Journal:  Neurochem Res       Date:  2022-03-18       Impact factor: 3.996

3.  Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy.

Authors:  Cristina R Reschke; Luiz F A Silva; Vamshidhar R Vangoor; Massimo Rosso; Bastian David; Brenton L Cavanagh; Niamh M C Connolly; Gary P Brennan; Amaya Sanz-Rodriguez; Catherine Mooney; Aasia Batool; Chris Greene; Marian Brennan; Ronan M Conroy; Theodor Rüber; Jochen H M Prehn; Matthew Campbell; R Jeroen Pasterkamp; David C Henshall
Journal:  Mol Ther       Date:  2021-02-18       Impact factor: 12.910

4.  Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.

Authors:  Srikant Rangaraju; Eric B Dammer; Syed Ali Raza; Tianwen Gao; Hailian Xiao; Ranjita Betarbet; Duc M Duong; James A Webster; Chadwick M Hales; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Mol Neurodegener       Date:  2018-06-28       Impact factor: 14.195

5.  A peripheral lipid sensor GPR120 remotely contributes to suppression of PGD2-microglia-provoked neuroinflammation and neurodegeneration in the mouse hippocampus.

Authors:  Kensuke Iwasa; Shinji Yamamoto; Kota Yamashina; Nan Yagishita-Kyo; Kei Maruyama; Takeo Awaji; Yoshinori Takei; Akira Hirasawa; Keisuke Yoshikawa
Journal:  J Neuroinflammation       Date:  2021-12-27       Impact factor: 8.322

6.  IRF2BP2-deficient microglia block the anxiolytic effect of enhanced postnatal care.

Authors:  Aswin Hari; Shelly A Cruz; Zhaohong Qin; Pascal Couture; Ragnar O Vilmundarson; Hua Huang; Alexandre F R Stewart; Hsiao-Huei Chen
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

Review 7.  The role of inflammation in the development of epilepsy.

Authors:  Amna Rana; Alberto E Musto
Journal:  J Neuroinflammation       Date:  2018-05-15       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.